Greenphire Named in Philadelphia Business Journal's Best Places to Work

Greenphire, the leading provider of payment technology for the clinical trials industry, today announced that it has been named as one of the best places to work in Philadelphia for the third time in four years.

The company has been listed in the Philadelphia Business Journal’s ‘Best Places to Work’ list, which recognizes and celebrates the outstanding workplace culture created by the very best employers in the Greater Philadelphia region. The prestigious list of 54 organizations, which Greenphire was also part of in 2012 and 2014, is created using responses from employee surveys and considers themes such work-life balance, respect, recognition, teamwork and commitment to the community. This year, Greenphire was selected from over 150 entries.

Greenphire’s Chief Experience Officer, Jennifer Peters, commented, “We are so proud to have been named one of the ‘Best Places to Work’ by the Philadelphia Business Journal for the third time. The team works tirelessly to develop the innovative and creative solutions which keep Greenphire at the top of its game. It is a high priority for us to create a workplace environment which is unique and inspiring, and that people want to be part of, so they excel.”

Since its inception in 2008, Greenphire’s exponential growth has propelled the company to become the clinical trial industry’s leading provider of payment technology. It is one of Philadelphia’s fastest growing organizations with 75 current employees and plans for further expansion to support its increasing client base.
 

About Greenphire

 
Greenphire is the industry’s leading provider of clinical payment technology, designed to change the way research professionals work. We leverage our proprietary workflow automation and advanced web?based payment technologies to help our clients improve operational efficiency, access clinical financial analytics, reduce costs, mitigate regulatory risks, increase subject retention and compliance, and produce quantifiable results that improve clinical operations and strategic planning.

Previous

Next